Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4-Deficient.
SMARCA4-deficient non-small cell lung cancer is characterized by highly aggressive clinical behavior, diverse tumor subtypes, and complex histological features.
APA
Zheng H, Cui Y, et al. (2026). Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4-Deficient.. Pathology international, 76(2), e70095. https://doi.org/10.1111/pin.70095
MLA
Zheng H, et al.. "Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4-Deficient.." Pathology international, vol. 76, no. 2, 2026, pp. e70095.
PMID
41653129
Abstract
SMARCA4-deficient non-small cell lung cancer is characterized by highly aggressive clinical behavior, diverse tumor subtypes, and complex histological features. The application of the SMARCA4 immunohistochemical marker facilitates accurate identification. This study presents a rare case of SMARCA4-deficient pulmonary invasive mucinous adenocarcinoma with high-grade transformation.
MeSH Terms
Humans; DNA Helicases; Adenocarcinoma, Mucinous; Lung Neoplasms; Nuclear Proteins; Transcription Factors; Male; Biomarkers, Tumor; Middle Aged; Female; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
같은 제1저자의 인용 많은 논문 (5)
- The Harms of Obesity in Abdominoplasty: Considerations of Methodological and Social Behavioral Factors.
- Diosgenin targets ITGA11-driven angiogenesis in hepatocellular carcinoma: Prognostic and mechanistic insights.
- Ablation for hepatocellular carcinoma in hepatitis B-related recompensated vs. compensated cirrhosis.
- Systems toxicology unravels multi-tiered carcinogenic networks of zearalenone in gastric cancer.
- Correspondence to "Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis".